•Codelivery of LY and CpG via PS nanosphere treatmentrevealed a striking 99.7% tumor inhibition rate compared to PS-LYalone group. This synergistic effect could be attributed to the CD8+T-cell immune responses. Here, CD8A is linked to neoplasm.